Stay updated on AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated to v3.5.2; v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:30:34.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T21:13:44.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:13:56.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:20:48.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:29:43.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    A 'Show glossary' toggle was added, the QC update label was changed to 'Last Update Submitted that Met QC Criteria', and a 'No FEAR Act Data' notice along with revision v3.4.0 was added.
    Difference
    0.2%
    Check dated 2026-01-28T21:24:51.000Z thumbnail image

Stay in the know with updates to AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.